31-07-2026 00:51 via drugs.com

Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status

THURSDAY, July 30, 2026-- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a...
Read more »